F2 Bioscience I 2017 Ltd - 10%+ Owner at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
CGEM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by F2 Bioscience I 2017 Ltd since 8/21/2023

Holdings reported by F2 Bioscience I 2017 Ltd for Cullinan Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.31M $16.3M $12.46 Jun 21, 2022 F2 Vision SCS
Common Stock 1.14M $14.2M $12.46 Jun 21, 2022 By Globeways Holdings Ltd.
Common Stock 622K $7.75M $12.46 Jun 21, 2022 By F2-TPO Investments, LLC
Common Stock 537K $6.7M $12.46 Jun 23, 2022 Direct
Common Stock 325K $4.05M $12.46 Jun 21, 2022 By F2 MG Ltd.
Common Stock 215K $2.68M $12.46 Jun 21, 2022 By F2 MC, LLC
Common Stock 113K $1.4M $12.46 Jun 21, 2022 By Morana Jovan-Embiricos
Common Stock 105K $1.31M $12.46 Jun 21, 2022 By F2 GC, LLC
Common Stock 71.6K $892K $12.46 Jun 21, 2022 By F2 Bio TD, LLC

Transactions reported by F2 Bioscience I 2017 Ltd for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.